Vivani Medical, Inc. presented at the Emerging Growth Conference in New York on July 15, 2026. During the presentation, CEO Dr. Adam Mendelsohn provided an update stating that the first dosing of the company's SLIM-1 is expected to occur in August 2026. Vivani Medical, Inc. is a biotechnology company focused on developing medical treatments.
